Dialysis world news


Kaiser Opens New Rainbow Dialysis Center in Lahaina - Maui Now

By Maui Now Staff

Kaiser Permanente held a blessing ceremony today for its newest facility on Maui.  The Rainbow Dialysis Center, a wholly owned subsidiary of Kaiser Permanente Hawai?i, is located at Lahaina Gateway, just minutes from Kaiser‘s Lahaina Clinic.  The new facility will begin treating patients in early May.

It is the second Rainbow Dialysis Center on Maui and has the capacity to treat approximately 18 kidney patients per day.  The first Rainbow Dialysis Center location opened in Wailuku in June 2012.

The 2,000-square-foot facility is equipped with six dialysis stations, including an isolation unit to provide treatment for patients with contagious illnesses.

Kaiser representatives say the center will leverage services to improve the quality of care and provide patients treatment closer to home.

“Unfortunately, diabetes and resulting kidney disease are common health issues in Hawai?i, making dialysis an essential treatment for so many people,” said Geoffrey Sewell, MD, president and executive medical director of Hawai?i Permanente Medical Group in a press release statement. “We’re pleased to be able to provide patients on the Valley Isle with greater access to high-quality dialysis care at our new location in Lahaina.”

The Lahaina facility location will be led by medical director Alan Lau, MD, chief of nephrology at Kaiser Permanente; and will be managed by DaVita, one of the nation’s largest kidney care providers.

“Making quality health care convenient and affordable has always been our priority,” said Mary Ann Barnes, RN, president of Kaiser Permanente Hawai?i and Rainbow Dialysis in the announcement. “We are proud to be here today celebrating our second dialysis center in the Maui community, which will make treatments easier for the island’s dialysis patients,” she said.

Exterior of Lahaina Rainbow Dialysis Center. Courtesy photo.

Rudy Marilla, vice president of clinic operations; Mary Ann Barnes, RN, president of Kaiser Permanente Hawaii and Rainbow Dialysis; Kahu Earl Kukahiko; and Geoffrey Sewell, MD, president and executive medical director of Hawaii Permanente Medical Group, at the blessing of Lahaina Rainbow Dialysis Center on April 30. Courtesy photo.

Interior of Lahaina Rainbow Dialysis Center. Courtesy photo.

Exterior of Lahaina Rainbow Dialysis Center. Courtesy photo.

image

Interior of Lahaina Rainbow Dialysis Center. Courtesy photo.

    Recommend This Article <![CDATA[ .post_section_header, .post_section_header_noleft { width:735px; height:45px; background:url(http://mauinow.com/wp-content/themes/MauiNow3/images/post_section_header.png) no-repeat; line-height:35px; font-family:Arial; font-weight:bold; font-size:15px; color:#666; text-transform:uppercase; position:relative; left:-30px; } .post_section_header_noleft { left:-5px !important; } .posttags a { margin-left:5px; margin-right:5px; color:#333; } ]]><![CDATA[ ul#similarposts { list-style:none; width:100%; margin:0px; padding:0px; } ul#similarposts li { list-style:none; width:24%; display:inline-block; margin:3px; padding:0px; float:left; } ul#similarposts li .image { width:100%; height:100px; border:1px solid #ccc; overflow:hidden; margin-bottom:8px; } ul#similarposts li .image img { width:100%; min-height:100%; } ul#similarposts li a { text-decoration:none; font-weight:bold; line-height:16px; font-family:Arial; font-size:13px; text-align:Center; } ]]>    You Might Also Like

...

 
Effingham Sheriff's Office hosting motorcycle ride for deputy - Savannah Morning News

Savannah Morning News

Effingham Sheriff's Office hosting motorcycle ride for deputy
Savannah Morning News
The Effingham County Sheriff's Office (ECSO) is asking for help in raising funds to assist Deputy Ivey Williamson, who is fighting End Stage Renal Disease (ESRD). Williamson has been in law enforcement for 20 years and is a current deputy with the ECSO.

and more »

...

 
SYMPLICITY AF trial will evaluate renal denervation, pulmonary vein isolation ... - Healio

Medtronic announced that enrollment has begun for the SYMPLICITY AF study, which will assess whether paroxysmal and persistent atrial fibrillation can be treated with a combination of renal denervation and pulmonary vein isolation.

Patients will be randomized to receive pulmonary vein isolation with a cardiac cryoablation system (Arctic Front Advance, Medtronic) alone, or pulmonary vein isolation plus renal denervation with a catheter (Symplicity Spyral, Medtronic) and a radiofrequency generator (Symplicity G3, Medtronic), according to a press release from the company. Renal denervation has previously been investigated as a treatment for hypertension.

All patients in the trial will receive an insertable cardiac monitor (Reveal LINQ, Medtronic) to detect and record recurrence of abnormal heart rhythms after randomization, according to the release.

“Hypertension is one of the most prevalent risk factors for developing AF, but we’ve seen that it is also potentially the most modifiable risk factor for halting the progression of the disease,” investigator Larry Chinitz, MD, director of the Heart Rhythm Center at NYU Langone Medical Center, said in the release. “As we continue to look for ways to prevent AF recurrence and improve outcomes for patients with AF, this trial may reveal a potential new treatment path for patients.”

The study will enroll up to 245 patients with paroxysmal or persistent AF from as many as 12 United States centers. Eligible patients will also have office-based systolic BP of 150 mm Hg or higher, despite receiving treatment with at least two antihypertensive therapies at the highest appropriate dose. Of those enrolled, 70 who meet all inclusion and no exclusion criteria will be randomized.

According to the release, the primary safety endpoint is comprised of events related to pulmonary vein isolation and renal denervation, and the primary efficacy endpoint is freedom from chronic treatment failure, defined as either AF of 30 seconds or longer or a required intervention for AF.

The renal denervation catheter and radiofrequency generator are not yet approved in the United States, and the cardiac cryoablation system is not yet approved for treatment of persistent AF, according to the release.

...

 
Open source practical manual for implementing home hemodialysis
Hemodialysis International: Encouraging clinical outcomes from observational and randomized controlled data in the forms of frequent hemodialysis (HD) has renewed interest in home HD. However, given its benefits, home HD is relatively underutilized throughout the world. The Global Forum for Home Hemodialysis, an independent panel comprised of internationally recognized nephrologists, home HD nurses, administrators, patient advocates, and a long-time home HD patient, has convened with the intention of creating an open-source, comprehensive, practical manual that provides useful information to clinicians who are interested in implementing home HD.

...

 
Low Physical Function Not Tied to Muscle Mass - Renal and Urology News

Renal and Urology News

Low Physical Function Not Tied to Muscle Mass
Renal and Urology News
Patients on maintenance hemodialysis(MHD) have worse physical function than elderly non-hemodialysis (non-HD) patients independent of muscle mass and co-morbidity, researchers reported online ahead of print in the Journal of Renal Nutrition.

...

 
<< Start < Prev 141 142 143 144 145 146 147 148 149 150 Next > End >>

Page 144 of 2630
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.